Evaluating heart health outcomes in pregnant individuals with heart disease
Official title: The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
Run by University of Missouri, Kansas City · NCT06517628 · Data updated 2026-11-12
This study looks at the health outcomes for pregnant people with heart disease to see how to improve care for them and their babies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | University of Missouri, Kansas City Academic / other |
| Locations | 1 site (Kansas City, Missouri) |
| Status | Recruiting |
| Started | January 14, 2025 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | January 20, 2025 |
| Trial ID | NCT06517628 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant individuals with one or more specific cardiovascular conditions, such as congenital heart disease, arrhythmias, or cardiomyopathies.
✕Probably not a fit
Patients who are unable to participate in follow-up or have conditions like traumatic aortic disease or peripartum cardiomyopathy diagnosed in the current pregnancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the obstetrical, neonatal, and cardiovascular outcomes of 1000 pregnant individuals with known heart disease. It seeks to identify optimal structures for cardio-obstetrics care to improve maternal and neonatal health outcomes. The study addresses the rising maternal mortality rates in the U.S., particularly among marginalized populations, by focusing on the significant impact of cardiovascular disease during pregnancy. By collecting prospective data, the study aims to uncover factors contributing to maternal morbidity and mortality, especially in communities disproportionately affected by these issues.
Why it matters
Potential benefit: If successful, this study could lead to improved care strategies that significantly reduce maternal and neonatal morbidity and mortality in pregnant individuals with heart disease.
How similar studies have gone: Other studies have highlighted the importance of addressing cardiovascular health in pregnancy, but this specific approach focusing on marginalized populations is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion: Must have one or more condition(s) within the 6 following categories - Repaired or Unrepaired * Congenital or structural heart disease * Aortopathies * Arrhythmias * Cardiomyopathies and Heart Failure * Coronary disease * Other (Current endocarditis or history of endocarditis, Pericarditis, Pericardial effusion - Moderate or Large, Pericardial constriction, Pulmonary hypertension (all types) defined as mean pulmonary artery systolic pressure of \>20 mmHg by right heart catheterization or pulmonary hypertension estimated in the severe range by echo) Exclusion Criteria * Unable to participate in telephone follow-up * Too hard of hearing to do follow-up by telephone or deaf * Incarcerated prisoner * History of dementia. * Subjects without a way for contact by telephone for follow-up * Refused participation in the study * Unable to consent for self * Traumatic Aortic Disease * Peripartum cardiomyopathy diagnosed in current pregnancy
Where it's running
-
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, United States Recruiting
Study contacts
- Principal investigator: John Spertus, MD, MPH — University of Missouri, Kansas City
- Study coordinator: Karen L Florio, DO, MPH
- Email: klwa42@umsystem.edu
- Phone: 631-579-1030
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating long-term complications of COVID-19 on lungs, heart, and kidneys
This study is trying to see if people who had COVID-19 have more problems with their lungs, heart, and kidneys compared to those who didn't have the virus.
-
Investigating vascular complications in children diagnosed with type 1 diabetes
This study is trying to see how type 1 diabetes affects heart health in children aged 8-18 by looking at things like blood pressure and diet over two years.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging
This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.
-
Womb Watch: using a smartphone app to detect fetal movements
This study tests a smartphone app to help pregnant people track fetal movements and see if it can better detect movement changes that might signal risk.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.